Nanome Webinar Series
Upcoming Live Stream:
Revealing the new Nanome CryoEM plugin to target Prion Aggregates with Antibodies in XR
Daniel Gruffat, MS
Revolutionizing Cancer Treatment: A Live Stream on the Latest Approved Inhibitor for Gastric Cancer Kinase Structures in Mixed Reality
Recorded March 24th, 2023
Deep dive into the crystal structure of Tyrosine Kinase KIT1 in complex with DP2976, a close chloro analog of ripretinib, the latest approved inhibitor for gastrointestinal cancer.
We provide a live examples of how multisite collaboration in Nanome and Mixed Reality looks like.
View on Demand
Roberta Bortolotta, PhD
Exploring the Crystal Structure of CRBN (Human Cereblon) Protein in Complex with Small Molecules for Drug Discovery Research: a Live Stream in Nanome and Quest Pro’s Mixed Reality
Recorded February 24th, 2023
We analyzed the crystal structure of human Cereblon in complex with DDB1 and lenalidomide (PDBid 4tz4) LIVE!
We’ll be showcasing Meta’s newest headset, the Meta Quest Pro, and viewers will be able to experience the Passthrough Mixed Reality capabilities along with Nanome’s powerful scientific use cases.
View on Demand
Jonathon Gast, PhD
Mike Bishop, PhD
Collaborative Drug Desing in XR
Recorded December 13th, 2022
How drug design and discovery can be improved across teams using XR.
From pocket characterization to docking, and more, teams from all over the world can still come together in space through the power of XR tools
How does the day-to-day look like for scientists that use Nanome
View on Demand
Seth Harris, PhD
Exploring structural data landscapes for drug discovery:
GYST, a Genentech platform with Nanome XR integration
Recorded November 9th, 2022
Large-scale data extracts and annotations of structural features can accelerate drug discovery and research
Genentech's platform GYST creates datasets and enables their exploration by a broad range of researchers, while also provisioning information for machine learning models
Custom plugins enable seamless integration of Nanome as a visualization and analytical component in this system
Zoran Radić, PhD
Virtual Reality to Aid Antidote Design:
Structure-based design to treat organophosphate poisoning
Recorded June 22nd, 2022
Understanding spatial impaction of Novichok-inhibited acetylcholinesterase is greatly facilitated by VR
3D structures of Acetylcholinesterase help explain its catalysis and provide a template for structure-based design while revealing an unexpected paradox
Structure-based analysis aided by VR accelerates the creation and refinement of antidotes against acetylcholinesterase poisoning
Brian Atwood, PhD
Rohit Arora, PhD
AI for the Science Metaverse:
how to accelerate drug discovery by using AI in VR
Recorded May 26th, 2022
Iktos AI-technologies for generative chemistry and retrosynthesis planning
Makya web application: AI for de novo drug design
Spaya web application: AI for discovering and prioritizing synthetic routes
Using Iktos tools in Nanome: a perfect place to collaborate
Andrey Kovalevsky, PhD
Designing from "inside" the COVID-19 viral protein:
A novel chemical structure designed in VR
Recorded January 26th, 2022
Novel chemical structures for inhibiting SARS-CoV-2 replication
VR-assisted structure-activity relationships
Why Oak Ridge National Laboratory combines neutrons and VR for structure-based drug design
How VR aids collaboration between structural biologists, medicinal chemists, and molecular modelers
A recording of this webinar is not available
Jackie von Salm, PhD
Psychedelics & Virtual Reality: How VR aids GPCR drug discovery for a psychedelic biotech startup
Recorded Wednesday, November 17th, 2021
Why psychedelic research is so promising & what's on the horizon
Overcoming the challenges of communicating scientific research to investors
Easy ways to improve spatial awareness of chemists and the impact that brings to the lab
How Psilera is using Nanome to filter compounds
View on Demand
The "Virtual" Reality of Drug Discovery at Novartis
Recorded Thursday, October 21st, 2021
How Novartis is using Virtual Reality across different research sites globally (US and Switzerland)
A case study of the main protease (Mpro) of SARS-CoV-2
Future outlook of VR at Novartis
A recording of this webinar is not available. Click below to download our case study with Novartis instead.
The Roivant Discovery vision for physics-driven drug design and the role of virtual reality to maximize insights.
Recorded Tuesday, August 24th, 2021
What Roivant Discovery is doing with physics-driven drug design.
The importance of structure-based drug discovery.
Why VR is the next step to fully realize the benefit of structure-based drug discovery for visualization, collaboration, and design.